Here's our list of the leaders in Massachusetts tech, biotech and climate tech who aren't just surviving, but moving their ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Researchers at the Paul Scherrer Institute PSI have developed an AI that could open up a new, cost-effective approach to ...

Nabla Bio's latest AI model update generates de novo antibodies for GPCRs with therapeutic-grade properties within a few ...

Scientists at Mass General Brigham in Boston have developed an AI tool called FaceAge, an algorithm designed to tell patients ...

Johns Hopkins University School of Medicine received a $10 million donation for an endowed AI center to further research and innovation in clinical and non-clinical spaces. There is rapid evolution of ...

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now.

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

For Charles Awoniyi, he stands at the forefront of healthcare transformation, leveraging his expertise in artificial ...

The artificial intelligence (AI) revolution is reshaping our world at an unprecedented pace. As AI technology evolves, it's ...